Regeneron: Omicron may reduce drug’s potency
Regeneron Pharmaceuticals Inc. unveiled in a statement on Monday that its monoclonal antibody COVID-19 drug may be somewhat less effective against coronavirus’ Omicron variant.
The company underl…
Harry T. Partner's Academy & fpmarkets
NOI SIAMO UN GRUPPO DI LAVORO PER QUESTO NON TI CHIEDIAMO SOLDI. CON NOI NON SARAI SOLO
